15.00 USD
↘ 0.34 (2.21%)LIVE (AS OF 11:50 AM EST)
Jade Biosciences, Inc. Common Stock (JBIO) trades at $15.00 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest JBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.